Compugen (CGEN) Non Operating Income (2009 - 2026)
Compugen (CGEN) reported Non Operating Income of $1.4 million for Q1 2026, up 8.67% on a YoY basis from $1.2 million in Q1 2025, and up 68.7% sequentially from $802000.0 in Q4 2025.
Compugen (CGEN) Non Operating Income (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Non Operating Income data on file, last reported at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 8.67% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (down 19.62% YoY), and the FY2025 full-year result was $4.1 million, down 21.44% from the prior year.
- Non Operating Income climbed to $1.4 million in Q1 2026, from $802000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.4 million in Q4 2024 to a low of $286000.0 in Q1 2022.
- A 5-year average of $914823.5 and a median of $889000.0 in 2023 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 266.67% in 2022 and tumbled 41.46% in 2025, its largest moves.
- Tracing CGEN's Non Operating Income over 5 years: stood at $495000.0 in 2022, then soared by 48.48% to $735000.0 in 2023, then surged by 86.39% to $1.4 million in 2024, then plunged by 41.46% to $802000.0 in 2025, then soared by 68.7% to $1.4 million in 2026.
- Business Quant data shows CGEN's Non Operating Income at $1.4 million in Q1 2026, $802000.0 in Q4 2025, and $954000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 | 1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 802,000.00 |
| Sep 30, 2025 | 954,000.00 |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 735,000.00 |
| Sep 30, 2023 | 776,000.00 |
| Jun 30, 2023 | 889,000.00 |
| Mar 31, 2023 | 808,000.00 |
| Dec 31, 2022 | 495,000.00 |
| Sep 30, 2022 | 464,000.00 |
| Jun 30, 2022 | 493,000.00 |
| Mar 31, 2022 | 286,000.00 |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | 177,000.00 |
| Jun 30, 2021 | 200,000.00 |